Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Surgepays Q4 2023 GAAP EPS $0.19 Misses $0.41 Estimate, Sales $32.318M Miss $33.521M Estimate

Author: Benzinga Newsdesk | March 12, 2024 04:06pm
Surgepays (NASDAQ:SURG) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.41 by 53.66 percent. The company reported quarterly sales of $32.318 million which missed the analyst consensus estimate of $33.521 million by 3.59 percent. This is a 10.79 percent decrease over sales of $36.226 million the same period last year.

Posted In: SURG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist